Cadre Holdings insider plans 24,000-share Rule 144 stock sale

Cadre Holdings insider files to sell additional shares under Rule 144.

Rhea-AI Filing Summary

Cadre Holdings insider files to sell additional shares under Rule 144. A holder plans to sell 24,000 shares of Cadre Holdings common stock through UBS Financial Services on the NYSE, with an aggregate market value of approximately $1,031,309.14. These shares were acquired as restricted stock units from the issuer on March 18, 2024.

As context, 40,663,844 shares of Cadre Holdings common stock were outstanding at the time of this notice. Over the past three months, the same seller completed multiple open-market sales, including a 27,370‑share transaction on November 13, 2025 that generated gross proceeds of $1,193,840. The seller represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CDRE disclose about insider stock sales?

The notice states that a holder intends to sell 24,000 shares of Cadre Holdings (CDRE) common stock under Rule 144 on the NYSE through UBS Financial Services, with an aggregate market value of about $1,031,309.14.

How many Cadre Holdings (CDRE) shares are outstanding in this Form 144?

The filing reports that 40,663,844 shares of Cadre Holdings common stock were outstanding when the notice was prepared.

How were the 24,000 Cadre Holdings (CDRE) shares being sold acquired?

The 24,000 shares planned for sale were acquired on March 18, 2024 as restricted stock units (RSUs) from the issuer.

What prior Cadre Holdings (CDRE) stock sales by this seller are disclosed?

Over the past three months, the seller completed several sales of Cadre Holdings common shares, including a 27,370‑share sale on November 13, 2025 that generated gross proceeds of $1,193,840.

Which broker is handling the planned Cadre Holdings (CDRE) sale and on which exchange?

The planned sale of 24,000 Cadre Holdings common shares is to be executed through UBS Financial Services Inc. on the NYSE.

>What representation does the seller make about Cadre Holdings (CDRE)?

By signing the notice, the seller represents that they do not know of any material adverse information about Cadre Holdings’ current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/10/2025 - 05:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001876053
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cadre Holdings, Inc.
SEC File Number	001-40698
Address of Issuer	13386 International Pkwy Jacksonville FLORIDA 32218
Phone	9047415400
Name of Person for Whose Account the Securities are To Be Sold	Brad Williams
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	24000	1031309.14	40663844	12/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2024	RSU	Issuer			24000	12/10/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brad Williams 13386 International Pkwy Jacksonville FL 32218	Common	09/23/2025	2541	93940
Brad Williams 13386 International Pkwy Jacksonville FL 32218	Common	09/23/2025	1591	58814
Brad Williams 13386 International Pkwy Jacksonville FL 32218	Common	10/14/2025	637	25455
Brad Williams 13386 International Pkwy Jacksonville FL 32218	Common	10/14/2025	3495	139695
Brad Williams 13386 International Pkwy Jacksonville FL 32218	Common	10/24/2025	4132	177546
Brad Williams 13386 International Pkwy Jacksonville FL 32218	Common	11/13/2025	27370	1193840

144: Remarks and Signature

Remarks
Date of Notice	12/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Brad Williams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)